Free Trial
LON:PXS

Provexis (PXS) Share Price, News & Analysis

GBX 0.71 -0.03 (-4.34%)
As of 08/12/2025 06:29 AM Eastern

About Provexis Stock (LON:PXS)

Key Stats

Today's Range
0.71
0.71
50-Day Range
0.53
0.90
52-Week Range
0.06
0.95
Volume
113,479 shs
Average Volume
1.18 million shs
Market Capitalization
£16.57 million
P/E Ratio
N/A
Dividend Yield
5.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter.

PXS Stock News Headlines

Paragon Care Limited (PXS) Receives a Buy from Ord Minnett
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Provexis Share Chat (PXS)
Pyxis Tankers: Bet On A Strong MR Product Tankers Market
See More Headlines

PXS Stock Analysis - Frequently Asked Questions

Provexis' stock was trading at GBX 0.65 at the beginning of 2025. Since then, PXS shares have increased by 8.6% and is now trading at GBX 0.71.

Provexis plc (LON:PXS) issued its quarterly earnings results on Wednesday, September, 30th. The company reported ($0.02) EPS for the quarter. Provexis had a negative trailing twelve-month return on equity of 68.68% and a negative net margin of 73.10%.

Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provexis investors own include Reckitt Benckiser Group (RB), Taylor Wimpey (TW), Bionano Genomics (BNGO), Bristol Myers Squibb (BMY), Bumble (BMBL), BEST (BEST) and Alibaba Group (BABA).

Company Calendar

Last Earnings
9/30/2020
Today
8/15/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Transportation
Current Symbol
LON:PXS
CIK
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£619.15 thousand
Net Margins
-73.10%
Pretax Margin
N/A
Return on Equity
-68.68%
Return on Assets
-56.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.62
Quick Ratio
6.21

Sales & Book Value

Annual Sales
£846.98 thousand
Price / Sales
19.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
GBX 0.01 per share
Price / Book
82.30

Miscellaneous

Outstanding Shares
2,346,582,006
Free Float
N/A
Market Cap
£16.57 million
Optionable
Not Optionable
Beta
1.21
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:PXS) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners